Nasus Pharma (NYSEAMERICAN:NSRX) Posts Earnings Results

Nasus Pharma (NYSEAMERICAN:NSRXGet Free Report) issued its quarterly earnings data on Monday. The company reported ($0.27) earnings per share for the quarter, FiscalAI reports.

Nasus Pharma Stock Up 2.2%

NYSEAMERICAN:NSRX opened at $3.70 on Tuesday. The business has a 50 day simple moving average of $3.20 and a 200-day simple moving average of $3.51. Nasus Pharma has a 1 year low of $1.98 and a 1 year high of $9.99.

Nasus Pharma Company Profile

(Get Free Report)

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.

Featured Stories

Receive News & Ratings for Nasus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nasus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.